| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/23/1998 | US5770431 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 06/23/1998 | US5770429 Transgenic non-human animals capable of producing heterologous antibodies |
| 06/23/1998 | US5770428 Chimeric retrovial expression vectors and particles containing a simple retroviral long terminal repeat, BLV or HIV coding regions and cis-acting regulatory sequences, and an RNA translational enhancer with internal ribsome entry site |
| 06/23/1998 | US5770427 Retrovirus from the HIV group and its use |
| 06/23/1998 | US5770422 Proteins, useful in diagnosis, therapy and in biopharmaceutical industry |
| 06/23/1998 | US5770421 Human ALK protein tyrosine kinase |
| 06/23/1998 | US5770404 Fermentation, incubation to produce culture product synthetic hemoglobin |
| 06/23/1998 | US5770403 Genetically engineered nucleic acid coding for antibodies which bind to and block interleukins |
| 06/23/1998 | US5770402 DNA encoding macrophage inflammatory protein-1γ |
| 06/23/1998 | US5770400 Exogenous gene expression vector containing chick β-actin gene promoter |
| 06/23/1998 | US5770398 Vector for integration site independent gene expression in mammalian host cells |
| 06/23/1998 | US5770396 Isolation characterization, and use of the human beta subunit of the high affinity receptor for immunoglobulin E |
| 06/23/1998 | US5770387 Antibodies to mammalian NK antigens and uses |
| 06/23/1998 | US5770385 Enzyme-linked immunosorbent assay to diagnose lung cancer |
| 06/23/1998 | US5770384 Method for determining compound interaction with E2 binding proteins |
| 06/23/1998 | US5770377 Detecting and preventing deactivation of tumor suppressors or anticarcinogenic agents |
| 06/23/1998 | US5770374 Methods for identifying oncogenes and anti-oncogenes |
| 06/23/1998 | US5770373 Rapid and sensitive detection of antibiotic-resistant mycobacteria using oligonucleotide probe specific for ribosomal RNA precursors |
| 06/23/1998 | US5770366 Melanoma-inhibiting protein |
| 06/23/1998 | US5770361 Protein conferring an inducible resistance to glycopeptides, particularly in gram-positive bacteria |
| 06/23/1998 | US5770357 Method of diagnosing caprine arthritis-encephalitis virus infection |
| 06/23/1998 | US5770356 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 06/23/1998 | US5770213 Endotoxin-free; otitis media, sinusitis, meningitis, and chronic pulmonary obstructive disease |
| 06/23/1998 | US5770212 Recombinant poxviruses with foreign DNA in essential regions |
| 06/23/1998 | US5770211 Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease |
| 06/23/1998 | US5770210 Expression of htlv-iii envelope proteins by recombinant dna methods, aids vaccine |
| 06/23/1998 | US5770209 Acceleration of wound healing using connective tissue growth factor |
| 06/23/1998 | US5770203 Modified cholera toxin based on mutagenized subunit A |
| 06/23/1998 | US5770202 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 06/23/1998 | US5770201 HA-2 antigenic peptide |
| 06/23/1998 | US5770197 Methods for regulating the immune response using B7 binding molecules and IL4-binding molecules |
| 06/23/1998 | US5770196 Modified antibody variable domains and therapeutic uses thereof |
| 06/23/1998 | US5770195 Antitumor |
| 06/23/1998 | US5770194 Fibrin sealant compositions and methods for utilizing same |
| 06/23/1998 | US5770192 Recombinant nuclear polyhedrosis virus, insecticide toxin |
| 06/23/1998 | US5770191 Active C-terminal peptides of interferon--gamma and their use |
| 06/23/1998 | US5769895 Delivery system for biologically active growth or morphogenetic factors and a method for preparing such a delivery system |
| 06/23/1998 | CA2222823A1 Composition of slap-130, a slp-76 associated protein and methods of use therefor |
| 06/23/1998 | CA2079887C Purification of a pertussis outer membrane protein |
| 06/20/1998 | CA2217698A1 Anti-obesity proteins |
| 06/19/1998 | CA2223076A1 Isolation and characterization of a gene encoding a low molecular weight glutenin |
| 06/18/1998 | WO1998026094A1 Reading frame independent epitope tagging |
| 06/18/1998 | WO1998026087A1 Bacillus strain and antibiotic screening method |
| 06/18/1998 | WO1998026084A1 Expression of active interferon beta 1 using recombinant rna replicons |
| 06/18/1998 | WO1998026083A1 Antifungal polypeptide and methods for controlling plant pathogenic fungi |
| 06/18/1998 | WO1998026082A1 Methods of using the nim1 gene to confer disease resistance in plants |
| 06/18/1998 | WO1998026080A1 Method for expression of heterologous proteins in yeast |
| 06/18/1998 | WO1998026079A1 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods |
| 06/18/1998 | WO1998026075A1 Non-m non-o hiv strains, fragments and applications |
| 06/18/1998 | WO1998026074A1 Fusion protein comprising the whole or part of the pp65 protein of human cmv, useable in particular for preparing a vaccine |
| 06/18/1998 | WO1998026073A1 Strain belonging to the genus bacillus and insecticidal proteins |
| 06/18/1998 | WO1998026072A1 Streptococcus pneumoniae dna sequences |
| 06/18/1998 | WO1998026071A1 Human cc chemokine elc |
| 06/18/1998 | WO1998026070A1 Bone stimulating factor |
| 06/18/1998 | WO1998026069A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026068A1 Human apoptosis-related calcium-binding protein |
| 06/18/1998 | WO1998026067A1 Adipocyte-specific differentiation-related protein |
| 06/18/1998 | WO1998026065A1 Mammalian icyp (iodocyanopindolol) receptor and its applications |
| 06/18/1998 | WO1998026064A2 Method for altering the nutritional content of plant seed |
| 06/18/1998 | WO1998026063A1 Nur-re a response element which binds nur nuclear receptors and method of use therefor |
| 06/18/1998 | WO1998026061A2 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 06/18/1998 | WO1998026057A1 Reduction of phosphorus containing components in edible oils comprising a high amount of non-hydratable phosphorus by use of a phospholipase, a phospholipase from a filamentous fungus having phospholipase a and/or b activity |
| 06/18/1998 | WO1998026051A2 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation |
| 06/18/1998 | WO1998026049A1 Recombinant equine herpesvirus type 1 (ehv-1) comprising a dysfunctional gene 71 region and use thereof as a vaccine |
| 06/18/1998 | WO1998026047A1 Methods and compositions for identifying morphogen analogs |
| 06/18/1998 | WO1998026046A2 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof |
| 06/18/1998 | WO1998025970A1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 06/18/1998 | WO1998025969A1 Von willebrand factor derivative and method for isolating proteins |
| 06/18/1998 | WO1998025968A1 Novel forms of class ii mhc transactivator (ciita) |
| 06/18/1998 | WO1998025967A1 Hvem polypeptides and uses thereof |
| 06/18/1998 | WO1998025966A1 Use of polypeptides for treating thrombocytopenia |
| 06/18/1998 | WO1998025965A2 Peptides and compounds that bind to the thrombopoietin receptor |
| 06/18/1998 | WO1998025964A1 Submucosa extracts |
| 06/18/1998 | WO1998025963A1 Analysis and separation of platelet-derived growth factor proteins |
| 06/18/1998 | WO1998025962A2 Secreted proteins and polynucleotides encoding them |
| 06/18/1998 | WO1998025961A1 Antimicrobially active polypeptides |
| 06/18/1998 | WO1998025960A1 Sequences derived from the genome of the c hepatitis virus, and use thereof |
| 06/18/1998 | WO1998025959A2 Secreted human proteins |
| 06/18/1998 | WO1998025958A2 Mammalian cell surface antigens comprising structural motifs characteristic of a member of the tnf ligand family |
| 06/18/1998 | WO1998025957A2 HUMAN Prt1-LIKE SUBUNIT PROTEIN (hPrt1) AND HUMAN eIF4G-LIKE PROTEIN (p97) GENES |
| 06/18/1998 | WO1998025956A2 Human gtp-binding proteins |
| 06/18/1998 | WO1998025955A2 Cloned glucagon-like peptide-2 receptors |
| 06/18/1998 | WO1998025953A1 Antimicrobial cationic peptides |
| 06/18/1998 | WO1998025951A1 Inhibitors of peptide binding to mhc class ii proteins |
| 06/18/1998 | WO1998025946A1 Monoclonal antibodies specific to endothelial cell cadherins and uses thereof |
| 06/18/1998 | WO1998025647A1 Calcium-independent modulation by cd81 of receptor signalling |
| 06/18/1998 | WO1998025646A1 Synthetic hpv16 virus-like particles |
| 06/18/1998 | WO1998025634A1 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 06/18/1998 | WO1998025574A2 Stimulation of an immune response to differentiation antigen stimulated by altered antigen |
| 06/18/1998 | WO1998025457A1 Composition and method for preserving progenitor cells |
| 06/18/1998 | WO1998018950A3 AAV-DNA helper virus sequences |
| 06/18/1998 | WO1998018919A3 GABAa Receptor subunit epsilon-related protein |
| 06/18/1998 | WO1998013500A3 Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines |
| 06/18/1998 | WO1998013385A3 Non-naturally occurring lipoprotein particle |
| 06/18/1998 | WO1998011242A3 Neurological disease model |
| 06/18/1998 | WO1998008961A3 Endosperm and nucellus specific genes, promoters and uses thereof |
| 06/18/1998 | WO1998008956A3 Use of a mutated macrolide binding protein for the prevention of gvhd |
| 06/18/1998 | WO1998000535A3 Method for inhibiting hiv-1 infection, drug screens, and methods of diagnosis and prognosis of susceptibility to hiv infection |
| 06/18/1998 | DE19727815C1 Monoclonal antibody specific for CD164 |
| 06/18/1998 | DE19727813C1 Monoclonal antibody specific for CD164 |